RTW INVESTMENTS, LP

Position in CELC — Celcuity Inc.

CIK 1493215 NEW YORK, NY

Position in CELC

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$346,942,340

+$292,069,382 QoQ

Shares Held

3,039,621

+452.5% QoQ

Ownership

6.23%

of shares outstanding

% of Portfolio

3.45%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2025

2 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

RTW INVESTMENTS, LP holds $8,256,157,304 across 64 Biotechnology names. CELC ranks #7 (4.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MDGL	Madrigal Pharmaceuticals, Inc.	1,993,687	$1,043,635,333
2	INSM	INSMED Inc	4,842,880	$791,907,737
3	PTGX	Protagonist Therapeutics, Inc	5,059,053	$533,224,186
4	PTCT	Ptc Therapeutics, Inc.	7,746,415	$527,763,253
5	ARGX	Argenx SE	709,446	$518,072,941
6	CGON	CG Oncology, Inc.	6,984,808	$472,731,805
7	CELC	Celcuity Inc. This page	3,039,621	$346,942,340
8	TNGX	Tango Therapeutics, Inc.	13,300,620	$278,248,970

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$346,942,340	3,039,621	+452.5%	Shares	Sole	2026-05-15
2025-12-31	$54,872,958	550,160	—	Shares	Sole	2026-02-17
No filing history on record for this holder in this stock.